Start for free
Start for free
ORI Capital logo

ORI Capital

Asia, Hong Kong Island, Hong Kong, Wan Chai

Description

ORI Fund is a venture capital fund that invests in innovative companies with disruptive technologies in the global healthcare industry.

Investor Profile

ORI Capital has made 9 investments, with 0 in the past 12 months and 67% as lead.

Stage Focus

  • Series B (44%)
  • Series C (22%)
  • Series E (11%)
  • Series D (11%)
  • Series A (11%)

Country Focus

  • United States (78%)
  • United Kingdom (22%)

Industry Focus

  • Health Care
  • Biotechnology
  • Health Diagnostics
  • Oncology
  • Medical Device
  • Medical
  • Therapeutics
  • Life Science
  • Manufacturing
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ORI Capital frequently co-invest with?

PC
Perseverance Capital Management
North America, California, United States, Los Angeles
Co-Investments: 2
CincyTech
CincyTech
North America, Ohio, United States, Cincinnati
Co-Investments: 2
Temasek Holdings
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Cintrifuse
Cintrifuse
North America, Ohio, United States, Cincinnati
Co-Investments: 2
F-Prime Capital
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Cowen Group
Cowen Group
North America, New York, United States, New York
Co-Investments: 2
Ohio Innovation Fund
Ohio Innovation Fund
North America, Ohio, United States, Columbus
Co-Investments: 2
Acorn Bioventures
Acorn Bioventures
North America, New York, United States, New York
Co-Investments: 1
Cincinnati Children’s
Cincinnati Children’s
North America, Ohio, United States, Cincinnati
Co-Investments: 2
Partisan Management Group
Partisan Management Group
North America, Colorado, United States, Evergreen
Co-Investments: 2

What are some of recent deals done by ORI Capital?

CG Oncology

Irvine, California, United States

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

BiotechnologyHealth CareHealth DiagnosticsOncology
Series ENov 15, 2022
Amount Raised: $120,000,000
CG Oncology

Irvine, California, United States

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

BiotechnologyHealth CareHealth DiagnosticsOncology
Series DDec 10, 2020
Amount Raised: $47,000,000
CG Oncology

Irvine, California, United States

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

BiotechnologyHealth CareHealth DiagnosticsOncology
Series CMar 18, 2019
Amount Raised: $22,000,000
Enable Injections

Cincinnati, Ohio, United States

Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.

Health CareLife ScienceManufacturingMedical Device
Series BOct 25, 2018
Amount Raised: $50,000,000
Orchard Therapeutics

London, England, United Kingdom

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BDec 20, 2017
Amount Raised: $110,000,000
Semma Therapeutics

Cambridge, Massachusetts, United States

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

BiotechnologyHealth CareMedicalTherapeutics
Series BNov 29, 2017
Amount Raised: $114,000,000
Arterys

San Francisco, California, United States

Arterys is a medical imaging platform to deliver clinical AI products over the internet.

Cloud ComputingHealth CareHealth DiagnosticsMedicalMedical Device
Series BNov 15, 2017
Amount Raised: $30,000,000
Kymab

Cambridge, Cambridgeshire, United Kingdom

Kymab is a clinical-stage biopharmaceutical company developing fully human monoclonal antibody therapeutics.

BiopharmaBiotechnologyTherapeutics
Series CNov 24, 2016
Amount Raised: $100,000,000
Enable Injections

Cincinnati, Ohio, United States

Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.

Health CareLife ScienceManufacturingMedical Device
Series AOct 5, 2016
Amount Raised: $30,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator